Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Equity, Diversity, and Inclusion
    • Without Borders
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Editorial Boards
    • Contact Us
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Equity, Diversity, and Inclusion
    • Without Borders
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Editorial Boards
    • Contact Us
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Resident & Fellow Section

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
American Academy of Neurology Journals
Home
  • Subscribe
  • My Alerts
  • Log in
Site Logo

Manuscript Categories

Back to Author Center

Neurology: Clinical Practice

Article type

Characteristics

Requirements

Policies

Research

Original contributions of direct relevance and importance to clinical practice. We will consider: prospective, observational and retrospective studies, meta-analyses and drug trials.

  • ≤3,000 Words (excluding abstract, tables, figure legends, appendices, and references)
  • Structured abstract with ≤250 words
  • ≤40 References
  • ≤5 Figures or tables 
  • 3-5 “take-home” points for a Summary Box
  • Requires use of relevant reporting guidelines and extensions, if applicable
  • Must include information on research ethics and informed consent
  • Requires data access statement
  • Requires Data Availability statement
  • Reports of clinical trials have additional requirements
  • Studies that evaluate therapeutic interventions, biomarkers, diagnostic accuracy studies, and studies on disease prognosis require a Classification of Evidence statement

Case Report

IMPORTANT: Most Case Reports will be published on-line only. Case Reports published on-line will be listed on the Table of Contents of a print issue.

Case reports should be concise and focus on unique manifestations or new observations of a clinical case. A good case report for practitioners should be unusual and informative to mechanism or educational and narrative. Evidence should be referenced from high quality studies, and discussion should concentrate on the risks and benefits in an individual patient (preferences, particular circumstances). Reports of clinical cases must have a clear message that might influence clinical practice.

  • ≤750 Words
  • Structured abstract with <200 words
  • ≤7 References
  • ≤2 Figures or tables
  • Provide a "Practical Implications" statement after the Title Page -- a pearl of wisdom for the practicing clinician, e.g. "Consider X in the differential diagnosis of Y" or "X imaging may be helpful in distinguishing Y in A patients"
  • Requires use of CARE guidelines
  • Requires data access statement
  • Requires information on research ethics and informed consent, and consent to disclose

Short Case

  • ≤250 Words
  • No abstract
  • ≤2 References
  • ≤2 Figures or tables

Review Article

Comprehensive, scholarly and balanced articles that present an expert examination of literature on a topic. We will consider: systematic reviews, meta-analyses and non-systematic/narrative reviews. Case reports or clinical vignettes used to illustrate a clinical approach or investigations/diagnosis/treatment to a challenging clinical or ethical presentation and accompanied by a comprehensive review of the literature should be submitted as a Review Article. Review Articles should comment on the quality of the available evidence and draw from the author’s practical experience about situations not covered by available evidence. Some Review Articles are invited, but the editors welcome unsolicited submissions and suggestions of topics/authors for consideration.

  • ≤3,000 Words
  • Structured abstract with ≤150 words with three subheadings: Purpose of Review, Recent Findings, Summary
  • Methods, if applicable
  • 40 References
  • ≤5 Figures or tables
  • Optional: Provide 3-5 "Take-home points"
  • Requires use of relevant reporting guidelines and extensions, if applicable

Five New Things

These articles are up-to-date reviews of recent findings in fields such as Parkinson disease, multiple sclerosis, gliomas and stroke.

  • ≤2,000 Words
  • Structured abstract with ≤150 words with three subheadings: Purpose of Review, Recent Findings, Summary
  • No methods
  • ≤25 References
  • ≤3 Figures or tables
  • Provide 5 bullet points for “Five New Things” Summary Box

Drugs and Devices

Drugs and Devices articles are reviews of recent advancements and timely issues concerning diagnostic tools and emerging therapies.

  • ≤2,000 Words (excluding abstract, tables, figure legends, appendices, and references)
  • Structured abstract with ≤150 words with three subheadings: Purpose of Review, Recent Findings, Summary
  • No methods
  • ≤25 References
  • ≤ 3 Figures or tables
  • Optional: Provide 3-5 "Take-home points"

Commentary

Timely analysis of current advances and insights into future directions of recent research findings, health policy issues, or practice management concerns of broad interest to clinical practice (e.g. diagnostic, therapeutic, political, social, ethical, economic, career, etc.) Where possible, authors should strive to make the material relevant to international readers as well as U.S. neurologists. Some Commentaries are invited, but the editors welcome unsolicited submissions and suggestions of topics/authors for consideration.

  • ≤1,500 Words
  • Unstructured abstract with ≤150 words
  • ≤25 References
  • ≤3 Figures or tables
  • Conclusion: Address the following questions in the Conclusion section: What are the unanswered questions? Where is the field going? What are the practical implications?

Back to Top

Neurology: Neuroimmunology & Neuroinflammation

Article type

Characteristics

Requirements

Policies

Article

Articles are full-length reports of original research. These include large-scale pivotal trials of new therapies (randomized clinical trials). The WHO's definition of a clinical trial that was adopted by the International Committee of Medical Journal Editors (ICMJE): "[a clinical trial is]…any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes." Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example, drugs, surgical procedures, devices, behavioral treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events. Observational studies are those in which individuals are observed and their outcomes are measured by the investigators.

  • ≤3,500 Words (excluding abstract, tables, figure legends, appendices, and references)
  • Structured abstract with ≤250 words
  • ≤40 References
  • ≤5 Figures or tables
  • (Alternatively, authors can limit to 3000 words and 6 figures or less are allowed).
  • Requires use of relevant reporting guidelines and extensions, if applicable
  • Must include information on research ethics and informed consent
  • Requires data access statement
  • Requires Data Availability statement
  • Reports of clinical trials have additional requirements
  • Studies that evaluate therapeutic interventions, biomarkers, diagnostic accuracy studies, and studies on disease prognosis require a Classification of Evidence statement

Articles (Smaller Scope Studies)

Neurology: Neuroimmunology & Neuroinflammation will consider smaller (e.g., 10-50 participants), uncontrolled, nonrandomized, or unblinded clinical trials as Articles. This category includes preliminary observations or pilot studies or presentation of one or a few informative cases. These manuscripts should be uploaded under "Article" in the Neurology: Neuroimmunology & Neuroinflammation tracking system. Editors will make final decisions regarding length of these articles.

  • ≤1,250 Words (excluding abstract, tables, figure legends, appendices, and references)
  • Structured abstract with ≤250 words
  • ≤10 References
  • ≤3 Figures or tables
  • Requires use of relevant reporting guidelines and extensions, if applicable
  • Must include information on research ethics and informed consent
  • Requires data access statement
  • Requires Data Availability statement

Clinical/Scientific Note

Clinical/Scientific Notes are abbreviated reports on cases or preliminary studies.

  • ≤750 Words
  • Structured abstract with <200 words
  • ≤7 References
  • ≤1 Figures or tables
  • Requires use of CARE guidelines
  • Requires data access statement
  • Requires information on research ethics and informed consent, and consent to disclose

Views & Reviews

Views & Reviews are either a review or an opinion statement that provides a summary of the most important recent information on a topic. If the Review summarizes recommendations for practice, use the word "Recommendations" in the title rather than "Guidelines." (Guidelines published in the Journal are created by an established process by the American Academy of Neurology.)

  • ≤3,500 Words
  • Structured abstract (optional) with ≤250 words
  • Methods, if applicable
  • 60 References
  • ≤6 Figures or tables
  • Requires use of relevant reporting guidelines and extensions, if applicable

Diagnostic and Treatment Challenges

This section features a classical case-report presentation and multidisciplinary discussion among physicians, with the aim to underscore the “pearls,” “pitfalls,” and fundamental principles that can be effectively integrated into practice. This educational offering will include cases selected from the Conference Webinars presented by the National Multiple Sclerosis Society Clinical Fellows and other submissions from readers of similarly formulated case reports and discussions from forums such as grand rounds or multidisciplinary conferences. Cases will include patients with any type of neuroimmunologic disease.

  • ≤2,000 Words
  • Structured abstract with <200 words
  • 20 References
  • ≤3 Figures or tables
  • Requires use of CARE guidelines
  • Requires data access statement
  • Requires information on research ethics and informed consent, and consent to disclose

Letters

The goal of this section is to encourage concise, rapid debate among authors and readers of Neurology: Neuroimmunology & Neuroinflammation Letters are restricted to comments about studies published in Neurology: Neuroimmunology & Neuroinflammation within the past two issues, with the exception of submissions identifying possible errors in data or data analysis or by appeal to the Editor. The letters will be edited for clarity and length. Readers wishing to submit a letter should access the article and click on "Comment" in the box at the top of the page. Letters are not indexed by PubMed.

  • ≤200 words
  • ≤Maximum of 5 references; reference 1 must be the article on which you are commenting
  • ≤5 authors (replies can incorporate full original article author list)

Authors of letters should keep the following statement from the Uniform Requirements for Medical Journal Editors in mind:

"Although editors have the prerogative to sift out correspondence material that is irrelevant, uninteresting, or lacking in cogency, they have a responsibility to allow a range of opinion to be expressed. The correspondence column should not be used merely to promote the Journal's or the editors' point of view. In all instances, editors must make an effort to screen out discourteous, inaccurate, or libelous statements, and should not allow ad hominem arguments intended to discredit opinions or findings."

Back to Top

Neurology: Genetics

Article type

Characteristics

Requirements

Policies

Article

Articles are full-length reports of original research. These include large-scale pivotal trials of new therapies (randomized clinical trials). The WHO's definition of a clinical trial that was adopted by the International Committee of Medical Journal Editors (ICMJE): "[a clinical trial is]…any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes." Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example, drugs, surgical procedures, devices, behavioral treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events. Observational studies are those in which individuals are observed and their outcomes are measured by the investigators.

  • ≤3,000 Words (excluding abstract, tables, figure legends, appendices, and references)
  • Structured abstract with ≤250 words
  • ≤40 References
  • ≤6 Figures or tables
  • If authors reach a maximum of 3500 words, they must have a limit of 5 figures and tables.
  • Requires use of relevant reporting guidelines and extensions, if applicable
  • Must include information on research ethics and informed consent
  • Requires data access statement
  • Requires Data Availability statement
  • Reports of clinical trials have additional requirements
  • Studies that evaluate therapeutic interventions, biomarkers, diagnostic accuracy studies, and studies on disease prognosis require a Classification of Evidence statement

Articles (Smaller Scope Studies)

Neurology: Genetics will consider smaller (e.g., 10-50 participants), uncontrolled, nonrandomized, or unblinded clinical trials as Articles. This category includes preliminary observations or pilot studies or presentation of one or a few informative cases. These manuscripts should be uploaded under "Article" in the Neurology: Genetics tracking system. Editors will make final decisions regarding length of these articles.

  • ≤1,250 Words (excluding abstract, tables, figure legends, appendices, and references)
  • Structured abstract with ≤250 words
  • ≤10 References
  • ≤3 Figures or tables
  • Requires use of relevant reporting guidelines and extensions, if applicable
  • Must include information on research ethics and informed consent
  • Requires data access statement
  • Requires Data Availability statement

Clinical/Scientific Note

Clinical/Scientific Notes are abbreviated reports on cases or preliminary studies.

  • ≤750 Words
  • Structured abstract with <200 words
  • ≤7 References
  • ≤1 Figures or tables
  • Requires use of CARE guidelines
  • Requires data access statement
  • Requires information on research ethics and informed consent, and consent to disclose

Views & Reviews

Views & Reviews are either a review or an opinion statement that provides a summary of the most important recent information on a topic. If the Review summarizes recommendations for practice, use the word "Recommendations" in the title rather than "Guidelines." (Guidelines published in the Journal are created by an established process by the American Academy of Neurology.)

  • ≤3,500 Words
  • Structured abstract (optional) with ≤250 words
  • Methods, if applicable
  • ≤60 References
  • ≤6 Figures or tables
  • Requires use of relevant reporting guidelines and extensions, if applicable

NeuroImages or Video NeuroImages

Submissions include photomicrographs, photographs, neuroradiologic images, and videos.

  • ≤100 Words
  • ≤50 Words in figure legend
  • ≤2 References
  • ≤2 Figures or 1 figure and 1 video
  • Requires information on research ethics and informed consent and consent to disclose

Letters

The goal of this section is to encourage concise, rapid debate among authors and readers of Neurology: Genetics Letters are restricted to comments about studies published in Neurology: Genetics within the past two issues, with the exception of submissions identifying possible errors in data or data analysis or by appeal to the Editor. The letters will be edited for clarity and length. Readers wishing to submit a letter can access the article and click on "Comment" in the box on the top of the article page. Letters are not indexed by PubMed.

  • ≤200 words
  • ≤Maximum of 5 references; reference 1 must be the article on which you are commenting
  • ≤5 authors (replies can incorporate full original article author list)

Authors of letters should keep the following statement from the Uniform Requirements for Medical Journal Editors in mind:

"Although editors have the prerogative to sift out correspondence material that is irrelevant, uninteresting, or lacking in cogency, they have a responsibility to allow a range of opinion to be expressed. The correspondence column should not be used merely to promote the Journal's or the editors' point of view. In all instances, editors must make an effort to screen out discourteous, inaccurate, or libelous statements, and should not allow ad hominem arguments intended to discredit opinions or findings."

Back to Top

Site Logo
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise